Home
Jan-Inge Bjune's picture

Jan-Inge Bjune

Postdoctoral Fellow
  • E-mailJan-Inge.Bjune@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen

Hormone Laboratory Research Group (https://www.uib.no/en/rg/hormonelaboratory)

Mohn Nutrition Research Laboratory (funded by the Mohn Foundation)

Co-supervising masterstudents

Academic article
  • Show author(s) 2021. Role of the Neutral Amino Acid Transporter Slc7a10 in Adipocyte Lipid Storage, Obesity and Insulin Resistance. Diabetes. 680-695.
  • Show author(s) 2021. Role of the Neutral Amino Acid Transporter Slc7a10 in Adipocyte Lipid Storage, Obesity and Insulin Resistance. Diabetes.
  • Show author(s) 2021. Genetic Deficiency of TRAF5 Promotes Adipose Tissue Inflammation and Aggravates Diet-Induced Obesity in Mice. Arteriosclerosis, Thrombosis and Vascular Biology. 2563-2574.
  • Show author(s) 2020. COL6A3 expression in adipose tissue cells is associated with levels of the homeobox transcription factor PRRX1. Scientific Reports. 1-11.
  • Show author(s) 2019. The homeobox factor Irx3 maintains adipogenic identity. Metabolism: Clinical and Experimental.
  • Show author(s) 2018. IRX5 regulates adipocyte amyloid precursor protein and mitochondrial respiration in obesity. International Journal of Obesity.
  • Show author(s) 2016. The cAMP-dependent protein kinase downregulates glucose-6-phosphatase expression through RORα and SRC-2 coactivator transcriptional activity. Molecular and Cellular Endocrinology. 92-101.
  • Show author(s) 2015. Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2). Scientific Reports.
Popular scientific lecture
  • Show author(s) 2018. CRISPR i fettceller: slankekur i sofaen?
Academic lecture
  • Show author(s) 2019. Irx3 er nødvendig for utvikling av fettceller .
  • Show author(s) 2018. Regulation of adipocyte metabolism by Irx3 and Irx5 .
  • Show author(s) 2018. Regulation of adipocyte browning by Irx3 and Irx5 .
  • Show author(s) 2018. IRX5 regulerer APP og mitokondriell respirasjon i fettceller .
  • Show author(s) 2017. Regulation of adipocyte browning by Irx5 .
  • Show author(s) 2016. Transcriptional regulation of adipocyte browning by homeobox factors Irx3 and Irx5.
Poster
  • Show author(s) 2018. Irx5 regulates body weight via amyloid precursor protein (App) and mitochondrial respiration in adipocytes.
  • Show author(s) 2018. Irx5 regulates body weight via amyloid precursor protein and mitochondrial respiration in adipocytes.
  • Show author(s) 2016. Repression of liver SRC-2 by metformin inhibits glucose, lipid and cholesterol biosynthesis.
  • Show author(s) 2016. PKA downregulates glucose-6phosphatase Expression through RORα and SRC2.
Academic literature review
  • Show author(s) 2017. Perceived Health Status: Is Obesity Perceived as a Risk Factor and Disease? Obesity Facts. 52-60.

More information in national current research information system (CRIStin)

2020

Bjune JI, Dyer L, Røsland GV, Tronstad KJ, Njølstad PR, Sagen JV, Dankel SN, Mellgren G. The homeobox factor Irx3 maintains adipogenic identity. Metabolism. 2020 Feb;103:154014. doi: 10.1016/j.metabol.2019.154014. Epub 2019 Nov 18. PMID: 31751577.

2019

Bjune JI, Haugen C, Gudbrandsen O, Nordbø OP, Nielsen HJ, Våge V, Njølstad
PR, Sagen JV, Dankel SN and Mellgren G. IRX5 regulates adipocyte amyloid
precursor protein and mitochondrial respiration in obesity
. Int J Obes 2019;43:2151-62.

2017

Visscher TL, Lakerveld J, Olsen N, Küpers L, Ramalho S, Keaver L, Brei C,
Bjune JI, Ezquerro S, Yumuk V. Perceived Health Status: Is Obesity Perceived as a Risk Factor and Disease? Obes Facts. 2017;10(1):52-60. doi:10.1159/000457958. Epub 2017 Mar 10. PubMed PMID: 28278496.

2016

Madsen A, Bjune JI, Bjørkhaug L, Mellgren G, Sagen JV. The cAMP-dependent
protein kinase downregulates glucose-6-phosphatase expression through RORα and SRC-2 coactivator transcriptional activity
. Mol Cell Endocrinol. 2016 Jan
5;419:92-101. doi: 10.1016/j.mce.2015.10.003. Epub 2015 Oct 9. PubMed PMID:
26455881.

2015
Madsen A, Bozickovic O, Bjune JI, Mellgren G, Sagen JV. Metformin inhibits
hepatocellular glucose, lipid and cholesterol biosynthetic pathways by
transcriptionally suppressing steroid receptor coactivator 2 (SRC-2)
. Sci Rep.
2015 Nov 9;5:16430. doi: 10.1038/srep16430. PubMed PMID: 26548416; PubMed Central PMCID: PMC4637908.